Sanofi Adr (SNY)

Sanofi ADS Stock (SNY) dropped by 19.13% from $53.33 to $43.13 in the trading on Friday October 27, 2023. The reason why SNY stock down today include

• Third-quarter financial results. Sanofi's earnings were 2.55 euros per share, tumbled 11.5% year over year and were 2% below expectations. Sales slipped 4.1% to 11.96 billion euros, or about $12.33 billion. Analysts expected a stronger 12.48 billion euros.
• Lower profit outlook: Sanofi expects its earnings per share to drop slightly in 2024, due to increased investment in research and development. The company has also abandoned its target of a 32% operating margin in 2025, in order to focus on long-term profitability.
• Spinout of its consumer care unit: Sanofi is considering spinning off its consumer health unit into a separate company as early as the end of next year. The unit, which sells over-the-counter pain relievers and allergy medications like Doliprane and Allegra, accounts for just over 10% of Sanofi's total sales. The spinoff would likely be done through a listing on the Paris stock exchange.